The interleukin-1 system (IL-1) is a prominent pro-inflammatory pathway responsible for the initiation and regulation of immune responses. Human genetic and preclinical studies suggest a critical role for IL-1β signaling in ethanol drinking and dependence, but little is known about the effects of chronic ethanol on the IL-1 system in addiction-related brain regions such as the central amygdala (CeA). In this study, we generated naïve, nondependent (Non-Dep) and dependent (Dep) male mice using a paradigm of chronic-intermittent ethanol vapor exposure interspersed with two-bottle choice to examine 1) the expression of IL-1β, 2) the role of the IL-1 system on GABAergic transmission, and 3) the potential interaction with the acute effects of ethanol in the CeA. Immunohistochemistry with confocal microscopy was used to assess expression of IL-1β in microglia and neurons in the CeA, and whole-cell patch clamp recordings were obtained from CeA neurons to measure the effects of IL-1β (50 ng/ml) or the endogenous IL-1 receptor antagonist (IL-1ra; 100 ng/ml) on action potential-dependent spontaneous inhibitory postsynaptic currents (sIPSCs). Overall, we found that IL-1β expression is significantly increased in microglia and neurons of Dep compared to Non-Dep and naïve mice, IL-1β and IL-1ra bidirectionally modulate GABA transmission through both pre-and postsynaptic mechanisms in all three groups, and IL-1β and IL-1ra do not alter the facilitation of GABA release induced by acute ethanol. These data suggest that while ethanol dependence induces a neuroimmune response in the CeA, as indicated by increased IL-1β expression, this does not significantly alter the neuromodulatory role of IL-1β on synaptic transmission.
Introduction
The interleukin-1 system (IL-1) is a prominent pro-inflammatory pathway responsible for the initiation and regulation of immune responses, but it has also received much attention for its pleiotropic neuromodulatory effects under physiological and pathophysiological conditions. In particular, its main cytokine ligand, IL-1β, has emerged as a key regulator of the ethanol-induced neuroimmune response, contributing to ethanol drinking and the development of ethanol dependence. Human genetic studies have found polymorphisms in genes encoding components of the IL-1β signaling pathway (i.e. IL-1ra (Il1rn) and IL-1β (Il1b)) associated with increased susceptibility to alcoholism (Pastor et al., 2005) , and IL-1β levels are elevated in the periphery and brain of alcoholic patients (Coleman et al., 2018; Zou and Crews, 2012; Achur et al., 2010) . Therefore, elucidating the mechanistic role of IL-1β in ethanol drinking and dependence is critical for understanding disease progression, as well as for the identification of novel therapeutic targets.
IL-1β is produced by caspase-1 cleavage of the inactive IL-1β precursor in response to specific immune receptor activation including: TLR4/IL-1R1, purinergic receptor or inflammasome complex (Mangan et al., 2018; Mehta et al., 2014; Dubyak, 2012; Montesinos et al., 2016; Alfonso-Loeches et al., 2014) . IL-1β exerts its effects by binding to its cognate IL-1R1 receptor, which subsequently associates with the IL-1R1 accessory protein (IL-1RAcP) to activate intracellular signaling through multiple effectors including: MyD88, PI3K/AKT, p38 MAPK, and NF-κB (O'Neill and Greene, 1998; Garlanda et al., 2013; Krumm et al., 2014) .
